AngioDynamics revenue rises 8% as NanoKnife sales surge
Compartilhar
AngioDynamics (NASDAQ:ANGO) reported fiscal fourth-quarter revenue of $86.6 million, up 8%, as Med Tech growth offset a wider $11.4 million GAAP net loss.
AngioDynamics (NASDAQ:ANGO) reported fiscal fourth-quarter revenue of $86.6 million, up 8%, as Med Tech growth offset a wider $11.4 million GAAP net loss.
